Australia's most trusted
source of pharma news
Friday, 23 January 2026
Friday, 23 January 2026
Subscribe
Login
News Headlines
News Headlines
News
Drs pick favourite obesity drug
Posted 23 January 2026 AM
Doctors have named oral semaglutide as their preferred up-and-coming obesity drug – and almost nine out of 10 expect to prescribe it within six months of its launch.
When asked to choose between Novo Nordisk’s oral semaglutide (Wegovy in a pill), Eli Lilly’s oral orforglipron and Novo’s injectable CagriSema, 71 per cent of US primary care physicians (PCPs) chose semaglutide.
To see the whole article, please login
Posted 23 January 2026 AM
Doctors have named oral semaglutide as their preferred up-and-coming obesity drug – and almost nine out of 10 expect to prescribe it within six months of its launch.
When asked to choose between Novo Nordisk’s oral semaglutide (Wegovy in a pill), Eli Lilly’s oral orforglipron and Novo’s injectable CagriSema, 71 per cent of US primary care physicians (PCPs) chose semaglutide.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (13)
- Sales & Key Account Associate - Melbourne
- Customer Service Representative - Pemulwuy
- Senior Territory Sales Manager - Melbourne
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- GP Sales Representative - Brisbane
- Pharmaceutical Sales Representative - Gold Coast
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Specialist Account Manager - Sydney
- Customer Service Specialist - Frenchs Forest
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (4)
- Clinical Research, Business Development Manager - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (5)
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Other (12)
- Dedicated Principal Agent - Pemulwuy
- Finance Administrator - Sydney
- GP Rep Bundaberg Contract - Bundaberg
- Warehouse & Logistics Officer - Macquarie Park
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
- Materials Planner - North Ryde
- Senior Recruitment Consultant - Sydney
- Warehouse Coordinator - Alexandria
- HR Analyst (Workday Specialist) - Melbourne
- Senior Recruitment Consultant - Sydney
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.